GlycoMimetics Incorporated

Quick facts

Phase 2 pipeline

• GMI-1070 · Oncology
  Inhibits the selectin family of adhesion molecules

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GlycoMimetics Incorporated portfolio CI brief
• GlycoMimetics Incorporated pipeline updates RSS